PYRIMIDO COMPOUNDS HAVING ANTIPROLIFERATIVE ACTIVITY
摘要
Disclosed are novel pyrimido compounds of the formula I that are selective inhibitors of both KDR and FGFR kinases and are selective against LCK. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and a process for their preparation.